Evidence map›Paper›PMID 31010902›Full record

ReviewJournal of bacteriology2019

Pushing beyond the Envelope: the Potential Roles of OprF in

Erin K Cassin, Boo Shan Tseng

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of bacteriology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. α-Mangostin attenuatesVirulence · 2026
    Article
  2. Targeting Outer Membrane Vesicles ofJournal of microbiology and biotechnology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. EPY001, a Novel Monoclonal Antibody AgainstInternational journal of molecular sciences · 2025
    Article
  13. Article
  14. Perturbation ofmBio · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Insights onMicroorganisms · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Erin K CassinSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, USA.
Boo Shan TsengSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, USA boo.tseng@unlv.edu.
University of Nevada, Las Vegas · US

Funding

Outreach/Diversity/Pipeline ProjectP20GM103440 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Jonathan E. Baker · 2012 to 2026
$58.0M
Matrix-associated proteins in biofilm tolerance: Psl and ecotinK22AI121097 · NIAID · UNIVERSITY OF NEVADA LAS VEGAS · PI TSENG, BOO SHAN · 2016 to 2017
$268k
NIAID NIH HHS K22 AI121097NIGMS NIH HHS P20 GM103440
6 · The paper itself

Abstract

The ability of

Indexed as

AnimalsBacterial ProteinsBiofilmsExtracellular MatrixHumansProteomicsPseudomonas aeruginosaVirulenceBacterial ProteinsOprF protein, Pseudomonas aeruginosa

Identifiers

PMID31010902
PMCPMC6707909
OpenAlexW2940576271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.